Sanofi Mounts Offensive For Eloxatin

Law360, New York (July 25, 2007, 12:00 AM EDT) -- Eloxatin is once again the subject of heavy litigation now that Sanofi-Aventis U.S. LLC has slammed generics makers with patent infringement suits over the hit colon cancer drug, just days after one of the companies sued for declaratory judgment to keep itself out of court.

Sanofi filed similar suits against Australian drug maker Mayne Pharma and India-based Sun Pharmaceutical Industries Ltd. in the New Jersey district court Monday, saying the generic heavyweights had filed Abbreviated New Drug Applications in violation of Sanofi's patents for the drug....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.